Back to News
Market Impact: 0.15
Arcutis Appoints Rob Scott, MD to Board of Directors
Source: globenewswire.com
Management & GovernanceHealthcare & Biotech
Arcutis appointed Rob Scott, MD, to its Board of Directors, effective October 23, 2026. The article describes Dr. Scott as a global pharmaceutical industry leader and pioneer but provides no further details on the appointment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
ARQT0.30
More News
- FedEx beats expectations, raises outlook in first report since calendar adjustment
- Warsh says politics played no role in Fed’s rate decision by group he is ’honored’ to lead
- Bausch Health raises 2026 outlook as third-quarter adjusted earnings surge 53%
- Tencent’s Cloud Boss Plays Long Game to Patch ‘Leaky’ AI Ship
- Microsoft reveals strong cloud growth amid financial reporting overhaul
- ECB to hold rates as investors focus on French bonds, Lagarde’s future